-
China’s first counter-sanction on US biotech industry marks a turning point in tech war
06 Feb 2025 08:45 GMT
… inclusion of a major US biotech company on its “unreliable entity list … firm Illumina is the first biotech company on Beijing’s list. More … Institute (BGI) and several other biotech companies on national security grounds, prompting …
-
Biotech company Alterity Therapeutics seeking to raise $40m
05 Feb 2025 23:03 GMT
-
Biotech company Alterity Therapeutics seeking to raise $40m
05 Feb 2025 22:44 GMT
-
Biotech Company Prints Medical Devices for the First Time on the International Space Station
05 Feb 2025 18:42 GMT
Auxilium Biotechnologies said it has successfully deployed its 3D bioprinter aboard the International Space Station (ISS). The company said this platform is the first of its kind, making history by printing eight implantable medical devices simultaneously …
-
Hundreds face layoffs as biotech company cuts jobs in Eastern Mass.
05 Feb 2025 04:42 GMT
… Fisher Scientific, a Waltham-based biotech company, is cutting 300 positions across …
-
Delaware biotech company plans to double workforce with state help
05 Feb 2025 02:23 GMT
-
Delaware biotech company plans to double workforce with state help
05 Feb 2025 02:19 GMT
A Delaware precision oncology company is planning to more than double its workforce during the next two years as it continues to advance its drug candidates targeting cancer.
Synnovation Therapeutics, which has 34 employees at The Innovation Space complex …
-
China designates Tommy Hilfiger owner and biotech company as unreliable entities
05 Feb 2025 01:21 GMT
China's Ministry of Commerce has sanctioned PVH Group, which owns the Tommy Hilfiger brand. (Credit: Shutterstock/Kamil Zajaczkowski)
China’s Ministry of Commerce took action against US-based Illumina and PVH Group for allegedly violating market …
-
BioNTech concludes acquisition of biotechnology company Biotheus
04 Feb 2025 23:19 GMT
… the previously announced acquisition of biotechnology company Biotheus for $800m, a move …
-
Duke professor-led biotech company raises $175 million to advance epigenome editing therapy clinical trials
31 Jan 2025 05:55 GMT
Tune Therapeutics, a Durham biotechnology startup co-founded by a Duke professor, announced the completion of its Series B fundraising round on Jan. 12, in which it raised $175 million to support clinical trials for its epigenome editor.
The company will …